Interobserver variability associated with the MIB-1 labeling index: High levels suggest limited prognostic usefulness for patients with primary brain tumors

Cancer

Volumn 92, Issue 10, 2001, Pages 2720-2726

  Mariegrzybicki, Dana ^a,b,c   Liu, Yulin ^a,b,c   Moore, Steven A ^a   Brown, Henry G ^a   Silverman, Jan F ^a   D'Amico, Frank ^a,b   Raab, Stephen S ^a,b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c DUQUESNE UNIVERSITY   (United States)

Author keywords

Astroglioma; Brain tumor; Interobserver variability; MIB 1; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; LABELING INDEX; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY;

ANTIGENS, NUCLEAR; BRAIN NEOPLASMS; GLIOMA; HUMANS; KI-67 ANTIGEN; NUCLEAR PROTEINS; OBSERVER VARIATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035889909     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011115)92:10<2720::AID-CNCR1626>3.0.CO;2-Z     Document Type: Article

References (55)

1. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1
2. Implications of prognostic markers in brain tumors
3. Clinicopathologic study of 85 similarly treated patients with anaplastic astocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
4. Prognostic significance of KI67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas
5. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas
6. Prognostic factors in supratentorial WHO Grade II astrocytoma in adults
7. Cellular proliferation in pilocytic and diffuse astrocytomas
8. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2′-deoxyuridine labeling indices, and mitotic figures in gliomas
9. Analysis of proliferation and apoptosis in brain gliomas: Prognostic and clinical value
10. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults
11. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization Grade 2 oligodendroglioma
12. Proliferative activity and prognosis of low-grade astrocytomas
13. Prognostic factors in oligodendroglioma
14. Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1
15. Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas
16. Clear cell meningioma variant and clinical aggressiveness
17. Pathological analysis of early recurrence and malignant transformation in histologically benign meningiomas
18. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors
19. Anaplastic pleomorphic astrocytoma
20. Central neurocytoma: Histologic atypia, proliferation potential, and clinical outcome
21. Ependymomas: MIB-1 proliferation index and survival
22. Recurrence in meningeal hemangiopericytomas
23. Expression of P27kipl and Ki-67 in pituitary adenomas: An investigation of markers of adenoma invasiveness
24. Clinicopathological study of pineal parenchymal tumors: Correlation between histopathological features, proliferative potential, and prognosis
25. Inter-observer variation on histopathological diagnosis and grading of vulvar intraepithelial neoplasia: Results of a European collaborative study
26. Histologic grading in breast cancer-reproducibility between seven pathologic departments
27. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists
28. Interobserver variability in application of the revised Sydney classification for gastritis
29. Cervical screening in Africa: Discordant diagnosis in a double independent reading
30. Methods to improve the reliability of histopathological diagnoses in the placenta
31. Discrepancies in diagnoses of neuroepithelial neoplasms. The San Francisco Bay Area Adult Glioma Study
32. Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients
33. An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens
34. Diagnostic concordance in biopsies of deceptive prostatic carcinoma
35. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance
36. Comparison of different scoring systems for immunohistochemical staining
37. Malignant mesothelioma of the pleura. The reproducibility of immunohistochemical diagnosis
38. C-erb-2 immunostaining: Problems with interpretation
39. Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium
40. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
41. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: Interlaboratory variance in the sensitivity of detection and evaluation of scoring systems
42. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters
43. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas
44. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: A study of 89 cases
45. MIB-1 labeling index in nonpilocytic astrocytoma of childhood. A study of 101 cases
46. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas
47. Prediction of recurrence in histologically benign meningiomas: Proliferating cell nuclear antigen and Ki-67 immunohistochemical study
48. Proliferation index as a predictor of prognosis in malignant gliomas of childhood
49. Clinical epidemiology
50. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas
51. Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus
52. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus
53. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR
54. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: A comparison